29th Jun 2007 13:14
Ark Therapeutics Group PLC29 June 2007 29 June 2007 Ark Therapeutics Group plc Voting Rights and Capital In accordance with the FSA's Disclosure and Transparency Rules, Ark TherapeuticsGroup plc (LSE: AKT) ("Ark" or the "Company") confirms that as at the date ofthis announcement the Company's issued share capital consists of 166,231,430ordinary shares with voting rights. This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to the interest in, Ark under the FSA's Disclosure and TransparencyRules. - Ends - This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PVG.L